Tongling Jieya Biologic Technology Co (301108) Fair Value & Analysis
Consumer Defensive · CN · Market cap 2.8B CNY
Fair value as of: Jun 24, 2026
Analysis
Tongling Jieya Biologic Technology Co (301108) currently trades at ¥25.14, while our model-based Fair Value estimate is ¥12.79 — implying the stock looks roughly 49.1% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
Tongling Jieya Biologic Technology Co., Ltd. engages in the research and development, production, and sales of wet wipe products in China. It offers baby, adult functional, antibacterial and disinfection, household clearing, medical care, pet cleaning wipes, wet toilet papers. The company also provides beauty care products, such as emollient water, Lotion, Cream, Essence, Membranes, clean, Body Series, Children's series, and Hair series, as well as facial masks and cleaning products. Tongling Jieya Biologic Technology Co., Ltd. was founded in 1999 and is based in Tongling, China.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Tongling Jieya Biologic Technology Co (301108) undervalued?
What is the fair value of 301108?
What is the quality score of 301108?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.